The Efficacy Gap: Oral vs Injectable Injectable tirzepatide (Zepbound), a dual GLP-1 and GIP receptor agonist, produced weight reductions of between 16% and 22.5% over 72 weeks in the SURMOUNT trials
IV Infusion Protocols and Dilution Requirements When giving Vitamin B12 IV, its important to stick to the right steps
Resting in a quiet, dark room can greatly ease headache pain
Starting a GLP-1 medication earlier in type 2 diabetes has the potential to not only improve blood sugar and promote weight loss, but also proactively protect the heart, kidneys, nerves, and overall metabolic health
Thus, incubating human and rodent islets under high glucose conditions results in increased expression of PC1/3 and increased secretion of GLP-1 (101, 108110), while exposure of -cells to the proinflammatory cytokine, interleukin-6, also increased GLP-1 secretion (112)
Purified IGF-1 and LR3 IGF-1 show bioactivity comparable to the standard IGF-1